Key result
Molecular pathology confirms rare primary pericardial synovial sarcoma surviving 22 months without therapy.
Why the study?
Primary pericardial synovial sarcoma is an extremely rare malignant tumor with a nonspecific presentation and a poor prognosis.
Case Report (n=1)
No
While multimodality imaging is essential for defining the anatomical extent of a giant intrapericardial mass, definitive diagnosis of primary pericardial synovial sarcoma requires an integrated pathological workup including histology, immunohistochemistry, and SS18 break-apart fluorescence in situ hybridization.
Answers are grounded in this paper and cite their sources.
Integrated molecular confirmation is essential for rare pericardial sarcomas; leaves open effective therapies in young adults.
Primary pericardial synovial sarcoma is an extremely rare malignant tumor with nonspecific presentation and poor prognosis. We report the case of a 29‐year‐old woman whose pericardial mass was detected during a workplace health examination. Transthoracic echocardiography revealed a giant intrapericardial mass predominantly compressing the left atrium. Computed tomography and magnetic resonance imaging demonstrated a heterogeneous intrapericardial mass extending from the left margin of the main pulmonary artery to the left atrioventricular groove, with partial invasion of the left atrial cavity. Ultrasound‐guided biopsy showed a monophasic spindle‐cell neoplasm. Immunohistochemistry showed focal weak positivity for pancytokeratin and epithelial membrane antigen, positivity for vimentin and D2‐40, weak positivity for CD99, and a Ki‐67 labeling index of approximately 15%. Fluorescence in situ hybridization using an SS18 break‐apart probe demonstrated split red and green signals in tumor‐cell nuclei, consistent with SS18 rearrangement. The patient declined surgical resection and adjuvant therapy and died 22 months after diagnosis. This case emphasizes that multimodality imaging is essential for defining tumor extent but cannot establish histological subtype. Integrated histology, immunohistochemistry, and SS18 fluorescence in situ hybridization are required for diagnostic confirmation.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) conducted a case report in Primary pericardial synovial sarcoma (n=1). Multimodality imaging and integrated pathological workup (ultrasound-guided biopsy, immunohistochemistry, and SS18 break-apart FISH); declined surgical resection and adjuvant therapy was evaluated on Definitive diagnosis and survival. Integrated histology, immunohistochemistry, and SS18 break-apart FISH confirmed a 101x76x96 mm primary pericardial synovial sarcoma in a 29-year-old woman who died 22 months after declining therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: